Ke Liang

4.7k citations
48 papers · 1.3k indexed · 1 hit paper · h-index 13

Ke Liang

43 papers receiving 1.3k citations

Hit Papers

Clinical Characteristics of Refractory Coronavirus Diseas...6532020202620222024200400600

Peers

Ke Liang
Comparison fields: 5 of 117
  • Infectious Diseases 1.0k
  • Neurology 529
  • Obstetrics and Gynecology 103
  • Modeling and Simulation 51
  • Oncology 241
Replace Shicheng Gao with:
Shicheng Gao China
Mingqi Luo China
Qingxian Cai China
Reena Shah Kenya
Shihui Song China
Pingzheng Mo China
Kate Webb United Kingdom
Jiaofeng Huang China
Su Aung United States
Muqing Yu China
Ke Liang relative to Shicheng Gao China Shicheng Gao's profile →
Citations per field
00.5×1.5×2.5×
Shicheng Gao · 1×
Citations per year

Countries citing papers authored by Ke Liang

Since Specialization
Citations

This map shows the geographic impact of Ke Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Liang more than expected).

Fields of papers citing papers by Ke Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Liang. The network helps show where Ke Liang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ke Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ke Liang Line = papers co-authored together Ke Liang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20251
4 20251
5 20251
6 20242
7 20240
8 20241
9 20243
10 20241
11 20232
12 20225
13 202212
14
Survival analysis of COVID-19 patients treated with different modes of respiratory support in the ICU
20211
15 202025
16 202012
17 20121
18 201144
19 20116
20 200932

About Ke Liang

Ke Liang is a scholar working on Infectious Diseases, Virology and Modeling and Simulation, having authored 48 papers that have together received 1.3k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (16 papers), COVID-19 Clinical Research Studies (16 papers), HIV/AIDS Research and Interventions (11 papers), Long-Term Effects of COVID-19 (8 papers), HIV, Drug Use, Sexual Risk (6 papers), Vaccine Coverage and Hesitancy (5 papers), COVID-19 Impact on Reproduction (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). The work is most often cited by research in Infectious Diseases (1.0k citations), Neurology (529 citations) and Obstetrics and Gynecology (103 citations). Ke Liang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Shicheng Gao, Pingzheng Mo, Yongxi Zhang, Mingqi Luo, Liping Deng, Yong Xiong, Xiaoping Chen, Zhiyong Ma, Shihui Song and Fan Wang. Their work appears in journals such as BMC Infectious Diseases, AIDS Research and Therapy, Frontiers in Immunology, AIDS Care and Frontiers in Public Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026